We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?

Detalles Bibliográficos
Autores principales: Cotta, Menino Osbert, Roberts, Jason A., Lipman, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893832/
https://www.ncbi.nlm.nih.gov/pubmed/27263664
http://dx.doi.org/10.1186/s13054-016-1348-8
_version_ 1782435624820670464
author Cotta, Menino Osbert
Roberts, Jason A.
Lipman, Jeffrey
author_facet Cotta, Menino Osbert
Roberts, Jason A.
Lipman, Jeffrey
author_sort Cotta, Menino Osbert
collection PubMed
description
format Online
Article
Text
id pubmed-4893832
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48938322016-06-07 We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how? Cotta, Menino Osbert Roberts, Jason A. Lipman, Jeffrey Crit Care Commentary BioMed Central 2016-06-06 2016 /pmc/articles/PMC4893832/ /pubmed/27263664 http://dx.doi.org/10.1186/s13054-016-1348-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Cotta, Menino Osbert
Roberts, Jason A.
Lipman, Jeffrey
We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
title We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
title_full We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
title_fullStr We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
title_full_unstemmed We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
title_short We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
title_sort we need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893832/
https://www.ncbi.nlm.nih.gov/pubmed/27263664
http://dx.doi.org/10.1186/s13054-016-1348-8
work_keys_str_mv AT cottameninoosbert weneedtooptimizepiperacillintazobactamdosingincriticallyillpatientsbuthow
AT robertsjasona weneedtooptimizepiperacillintazobactamdosingincriticallyillpatientsbuthow
AT lipmanjeffrey weneedtooptimizepiperacillintazobactamdosingincriticallyillpatientsbuthow

Ejemplares similares